biotechnologyFDA Fast-Tracks Lung Cancer Drug as Biotech Sector Logs $430M in DealsSalvado•Apr 16, 2026
biotechnologyArtiva Biotherapeutics faces $50-150M capital gap as NK cell therapy trials advanceViaNews Editorial Team•Mar 7, 2026
Biotechnology & Life SciencesThe Fragile Chain: How One Logistics Provider's 701-Trial Backlog Exposes a Global Cell Therapy BottleneckViaNews Editorial Team•Feb 18, 2026
Health & ScienceCellectis Bets on Off-the-Shelf CAR-T Revolution as $700M Peak Sales Forecast Puts Global Cell Therapy Race in FocusViaNews Editorial Team•Feb 18, 2026
